The renin-angiotensin-aldosterone system (RAAS) participates in the in
jury sustained by the remnant kidney, Our studies assessed the importa
nce of aldosterone in that model and the response of aldosterone to dr
ugs interfering with the RAAS, Initially, four groups of rats were stu
died: SHAM-operated rats, untreated remnant rats (REM), REM rats treat
ed with losartan and enalapril (REM AIIA), and REM AIIA rats infused w
ith exogenous aldosterone (REM AIIA + ALDO), The last group was mainta
ined with aldosterone levels comparable to those in untreated REM rats
by constant infusion of exogenous aldosterone. REM rats had larger ad
renal glands and a > 10-fold elevation in plasma aldosterone compared
to SHAM, REM. AIIA rats demonstrated significant suppression of the hy
peraldosteronism as well as marked attenuation of proteinuria, hyperte
nsion, and glomerulosclerosis compared to REM, REM AIIA + ALDO rats ma
nifested greater proteinuria, hypertension, and glomerulosclerosis tha
n REM AIIA rats, Indeed, by 4 wk of observation all of these features
of the experimental disease were similar in magnitude in REM AIIA + AL
DO and untreated REM, In separate REM rats spironolactone administrati
on did not reduce glomerular sclerosis but did transiently reduce prot
einuria, lowered arterial pressure, and lessened cardiac hypertrophy,
In summary, aldosterone contributes to hypertension and renal injury i
n the remnant kidney model.